Xtl Biopharmaceuticals (XTLB) Assets (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) posted quarterly Assets of $166000.0 for Q4 2025, down 98.06% year-on-year from $8.6 million in Q4 2024, and down 76.75% on a QoQ basis from $714000.0 in Q2 2025.
Xtl Biopharmaceuticals (XTLB) Assets (2009 - 2025) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Assets for 17 consecutive years, with $166000.0 the latest figure, recorded in Q4 2025.
- Quarterly Assets fell 98.06% year-over-year to $166000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $166000.0 (down 98.06% YoY) and the FY2025 annual result came in at $166000.0, down 98.06% from the prior year.
- Assets eased to $166000.0 in Q4 2025 per XTLB's latest filing, from $714000.0 in the prior quarter.
- Over the last five years, Assets for XTLB reached as high as $9.3 million in Q3 2024 and fell as low as $166000.0 in Q4 2025.
- A 5-year average of $4.7 million and a median of $4.5 million in 2022 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets surged 252.43% — and 2025, when it slumped 98.06%.
- Year by year, Assets stood at $6.6 million in 2021, then tumbled by 36.75% to $4.2 million in 2022, then sank by 42.04% to $2.4 million in 2023, then jumped by 252.43% to $8.5 million in 2024, then sank by 98.06% to $166000.0 in 2025.
- According to Business Quant data, Assets over the past three periods registered $166000.0, $714000.0, and $8.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | 166,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Dec 31, 2024 | 8.55 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 6.62 Mn |
| Dec 31, 2021 | 6.62 Mn |
| Sep 30, 2021 | 6.86 Mn |
| Jun 30, 2021 | 6.95 Mn |
| Mar 31, 2021 | 7.31 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 6.21 Mn |